Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT03321890 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: Chidamide
DRUG: prednisone
DRUG: Cyclophosphamide
DRUG: etoposide
DRUG: Methotrexate

Sponsor

Sun Yat-sen University